#156: Results from ESC 2012; TRILOGY ACS: No win for prasugrel; WOEST: Drop aspirin in stent patients on oral anticoagulants; ALTITUDE: New data on why trial halted; PARAMOUNT phase 2; IABP SHOCK II; New European STEMI guidelines; HPS2-THRIVE

Results from ESC 2012; TRILOGY ACS: No win for prasugrel; WOEST: Drop aspirin in stent patients on oral anticoagulants; ALTITUDE: New data on why trial halted; PARAMOUNT phase 2: Agent shows promise in preserved-EF HF; IABP SHOCK II: No survival benefit o

Source: Radio TheHeart.org - August 31, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts